MASTER DAPT trial: dual antiplatelet therapy after coronary stenting in high bleeding risk patients

Sponsored by Terumo

Anchorperson (Live from the studio): H. C. Tan

Discussant (Live from the studio)s: I. S. Saqib, J. W. C. Tan

Summary

In this session dedicated to the MASTER DAPT trial, find out more about the clinical study design and results, get acquainted with the new insights of its clinical outcome for high bleeding risk patients, and learn how the results bridge the gap and cover the unmet need for data on DAPT duration in HBR patients.

Learning Objectives

To find out more about the MASTER DAPT clinical study design and results
To get acquainted with the new insights of MASTER DAPT clinical outcome for high bleeding risk patients
To learn how MASTER DAPT results bridge the gap and cover the unmet need for data on DAPT duration in HBR patients